VEGFA and cancer: The reduced level of VEGFR2 phosphorylation may give support to the fact that expressions of molecules, including Akt, Erk and eNOS, closely belonging to VEGF–VEGFR2 signaling mechanism, were remarkably suppressed by piceatannol application in both endothelial cells and cancer cells.